Further, CD4+ Type II NKT cells were shown as regulators of diabetes and it was shown that these cells were sufficient in down-regulating diabetes, promoting activity of CD4+ BDC2.5 tg T cells in vivo. The gene discussed is CD4; the disease is diabetes mellitus.